Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 15/3/2021
SIETES contiene 93212 citas

 1 a 20 de 60 siguiente >>
Presentar resultados
Seleccionar todas
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page II RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2019;39:enero. [Ref.ID 103011]
3. Cita con resumen
Schuster RM , Gilman J , Schoenfeld D , Evenden J , Hareli M , Ulysse C , Nip E , Hanly A , Zhang H , Evins E. One month of cannabis abstinence in adolescents and young adults is associated with improved memory. J Clin Psychiatry 2018;79:. [Ref.ID 102839]
5. Cita con resumen
Strom BL, Schinnar R, Karlawish J, Hennessy S, Teal V, Bilker WB. Statin therapy and risk of acute memory impairment. JAMA Intern Med 2015;175:1399-405. [Ref.ID 99143]
6. Cita con resumen
Anónimo. Chantix (varenicline): Drug Safety Communication - FDA updates label to include potential alcohol interaction. U.S. Food and Drug Administration 2015:9 de marzo. [Ref.ID 98840]
7. Cita con resumen
Anónimo. Zolpidem. Continued reporting of abnormal sleep-related events and amnesia. WHO Pharmaceuticals Newsletter 2012;4:12-3. [Ref.ID 93681]
8. Cita con resumen
Anónimo. Zolpidem: continued reporting of abnormal sleep-related events and amnesia. Australian Prescriber 2012;35:99. [Ref.ID 92636]
9. Cita con resumen
Anónimo. Zolpidem oral spray (Zolpimist) for insomnia. Med Lett Drugs Ther 2012;54:14-5. [Ref.ID 92428]
10. Cita con resumen
Anónimo. Hypnotics. MeReC Bulletin 2012;22:8-10. [Ref.ID 92154]
11.Tiene citas relacionadas Cita con resumen
Chavant F, Favrelière S, Lafay-Chebassier C, Plazanet C, Pérault-Pochat M-C. Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database. Br J Clin Pharmacol 2011;72:898-904. [Ref.ID 91872]
12. Cita con resumen
Palm U, Geiger J, Lieb M. Emergence delirium after propofol anaesthesia. Eur J Clin Pharmacol 2011;67:209-10. [Ref.ID 90127]
14. Cita con resumen
Winstock AR, Ford C, Witton J. Assessment and management of cannabis use disorders in primary care. BMJ 2010;340:800-4. [Ref.ID 88314]
15.Tiene citas relacionadas Cita con resumen
Read J, Bentall R. The effectiveness of electroconvulsive therapy: A literature review. Epidemiologia e Psichiatria Sociale 2010;19:333-47. [Ref.ID 87531]
16. Cita con resumen
Anónimo. Uncommon knowledge. Drug Ther Bull 2009;47:121. [Ref.ID 87031]
17. Cita con resumen
Roca B. Farmacogenómica de los antirretrovirales. Med Clin (Barc) 2009;132:268-71. [Ref.ID 85491]
18. Cita con resumen
Zuurman L, Ippel AE, Moin E, van Gerven JMA. Biomarkers for the effects of cannabis and THC in healthy volunteers. Br J Clin Pharmacol 2009;67:5-21. [Ref.ID 84981]
19. Cita con resumen
Bardés I, Pujadas F, Ibarria M, Boada M. Amnesia global transitoria tras la toma de tadalafilo. Med Clin (Barc) 2008;131:78. [Ref.ID 83379]
20.Tiene citas relacionadas Cita con resumen
Marson AG, Tudur-Smith C, Williamson PR, Chadwick DW. Old versus new antiepileptic drugs: the SANAD study. Authors' reply. Lancet 2007;370:315-6. [Ref.ID 80666]
Seleccionar todas
 1 a 20 de 60 siguiente >>